Skip to content
value.today

Kinemed Inc.

Total raised
$21 M
5 rounds on record
Latest round
$2 M
Jun 2015
First round on record
Aug 2009
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Kinemed Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2015$2 MNo. 5$2 to $10 million

Kinemed Inc.: Raise no. 5, Jun 2015

Investors in this round

40 investors had bought by the notice of Jul 24, 2015: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $13 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$96,145
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David M Fineman · Executive Officer, Director
  • Matthew M Loar · Executive Officer
  • Patrick J. Doyle · Executive Officer, Director
  • Charles J. Casamento · Director
  • James S.J. Manuso · Director
  • K. Peter K Hirth · Director
  • Marc M Hellerstein · Director
  • Robert K Curry · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Feltl and Company, Inc. (CRD 6905) · Minneapolis, MinnesotaSold in AZ, CA, IL, LA, MN, OH, TX

Signed by David Fineman, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 24, 2015. Read the notice at the SEC.

equitySEC
Aug 2013$8 MNo. 4$2 to $10 million

Kinemed Inc.: Raise no. 4, Aug 2013

Investors in this round

131 investors had bought by the notice of Jan 13, 2014: 131 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$609,951
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David M Fineman · Executive Officer, Director
  • Marc M Hellerstein · Executive Officer, Director
  • Charles J. Casamento · Director
  • Henry K Settle Jr. · Director
  • James S.J. Manuso · Director
  • K. Peter K Hirth · Director
  • Robert K Cury · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Western Pacific Securities LLC (CRD 26354) · Fresno, CaliforniaSold in CA, CO, KS, NC, NV, OH, WY
  • Bedminister Financial Group, Limited (CRD 39916) · Westport, ConnecticutSold in FL, PA
  • Westlake Securities, LLC (CRD 127112) · Austin, TexasSold in FL

Signed by David M. Fineman, Chairman and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 13, 2014. Read the notice at the SEC.

equitySEC
Dec 2012$1 MNo. 3Under $2 million

Kinemed Inc.: Raise no. 3, Dec 2012

Investors in this round

25 investors had bought by the notice of Dec 13, 2012: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $5 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$103,985
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David M. Fineman · Executive Officer, Director
  • James S.J. Manuso · Director
  • Marc M. Hellerstein · Director
  • Robert E. Curry · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Western Pacific Securities LLC (CRD 26354) · Fresno, CaliforniaSold in CA, CO, KS, NC, SC, TX

Remarks in the notice

  • On the amounts: “Amount that will be received upon exercise of warrants is not included in Total Offering Amount or Total Amount Sold.”

Signed by David M. Fineman, President. Source: SEC Form D, newest notice filed Dec 13, 2012. Read the notice at the SEC.

equity, debt, optionsSEC
Oct 2010$4 MNo. 2$2 to $10 million

Kinemed Inc.: Raise no. 2, Oct 2010

Investors in this round

78 investors had bought by the notice of Nov 10, 2011: 78 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $6 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$253,495
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David M. Fineman · Executive Officer, Director
  • Henry C. Settle, III · Director
  • James S.J. Manuso · Director
  • Marc M. Hellerstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ledgemont Capital Group (CRD 145009) · New York, New YorkSold in CA, CO, CT, FL, IL, KS, NJ, NY, OH, TX, WY
  • Western Pacific Securities LLC (CRD 26354) · Fresno, CaliforniaSold in CA, CO, CT, FL, IL, KS, NC, NJ, NY, OH, TX, WY

Remarks in the notice

  • On the amounts: “"$750,000 included in ""Total Amount Sold"" will only be received upon exercise of warrants."”

Signed by David M. Fineman, President. Source: SEC Form D and 1 amendment, newest notice filed Nov 10, 2011. Read the notice at the SEC.

equity, optionsSEC
Aug 2009$6 MNo. 1$2 to $10 million

Kinemed Inc.: Raise no. 1, Aug 2009

Investors in this round

127 investors had bought by the notice of Jan 8, 2010: 127 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $8 M offered; $2 M still to sell
Smallest investment taken
$2,500
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$100,000
Finders' fees
$30,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David M. Fineman · Executive Officer, Director
  • Robert B. Stein · Executive Officer, Director
  • Edward S.J. Neugeboren · Director
  • James S.J. Manuso · Director
  • Marc B. Hellerstein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ledgemont Capital Group (CRD 145009) · New York, NySold in no state named
  • Western Pacific Securities (CRD 26354) · Fresno, CaSold in no state named

Signed by David M. Fineman, President. Source: SEC Form D and 2 amendments, newest notice filed Jan 8, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Kinemed Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2015).

    SEC Form D · Jul 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2015

That is all the official record says: Kinemed Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Kinemed Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 131 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Kinemed Inc.
NameRoleNamed in
David M FinemanExecutive officerJul 2015
Matthew M LoarExecutive officerJul 2015
Patrick J. DoyleExecutive officerJul 2015
Marc M HellersteinExecutive officerJun 2015
Matthew M. LoarExecutive officerJun 2015
David M. FinemanExecutive officerAug 2013
Marc M. HellersteinExecutive officerAug 2013
Robert B. SteinExecutive officerJan 2010
Charles J. CasamentoDirectorJul 2015
David M FinemanDirectorJul 2015
James S.J. ManusoDirectorJul 2015
K. Peter K HirthDirectorJul 2015
Marc M HellersteinDirectorJul 2015
Patrick J. DoyleDirectorJul 2015
Robert K CurryDirectorJul 2015
Henry K Settle Jr.DirectorJan 2014
Robert K CuryDirectorJan 2014
David M. FinemanDirectorAug 2013
James E. BurdenDirectorAug 2013
K. Peter E. HirthDirectorAug 2013
Marc M. HellersteinDirectorAug 2013
Robert E. CurryDirectorAug 2013
Henry C. Settle, IIIDirectorNov 2011
Edward S.J. NeugeborenDirectorSep 2011
Marc B. HellersteinDirectorJan 2010
Robert B. SteinDirectorJan 2010
Edward NeugeborenDirectorSep 2009
Marc HellersteinDirectorSep 2009